Proteomics profiling of CD4 + T-cell-derived exosomes from patients with rheumatoid arthritis
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110560 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Lixin Huang und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China; Department of Rheumatology and Immunology, Guangdong Second Pr…. Hauptthemen laut MEDLINE: Exosomes, Arthritis, Rheumatoid. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: Our study profiled the CD4 + T-cell-derived exosomes from patients with rheumatoid arthritis (RA) using proteomics. METHODS: Proteomic analysis of CD4 + T-cell-derived exosomes was performed by tandem mass tags (TMT) combined with LC-MS/MS. We validated the most significantly upregulated and downregulated proteins using ELISA and WB. RESULTS: The proteomic results showed that there were 3 upregulated differentially expressed proteins and 31 downregulated differentially expressed proteins in the RA group. The results indicated that dihydropyrimidinase-related protein 3 (DPYSL3) was significantly upregulated in CD4 + T-cell-derived exosomes, whereas proteasome activator complex subunit 1 (PSME1) was significantly downregulated in the RA group. Bioinformatics analysis showed that proteins were enriched in "positive regulation of gene expression", "antigen processing and presentation", "acute-phase response" and "PI3K-AKT signaling" pathways. ELISA verified that compared to the control group, the RA group showed significant upregulation of DPYSL3, and downregulation of PSME1 in CD4 + T-cell-derived exosomes. CONCLUSIONS: The proteomic analysis results of CD4 + T-cell-derived exosomes from patients with RA suggest that these differentially expressed proteins may be involved in RA pathogenesis. DPYSL3 and PSME1 may become useful biomarkers for RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China; Department of Rheumatology and Immunology, Guangdong Second Provincial General Hospital, Guangzhou, China.
- The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, China.
- Department of Rheumatology and Immunology, Guangdong Second Provincial General Hospital, Guangzhou, China.
- Department of Rheumatology and Immunology, Guangdong Second Provincial General Hospital, Guangzhou, China. Electronic address: 15088097855@163.com.
- Department of Rheumatology and Immunology, Guangdong Second Provincial General Hospital, Guangzhou, China. Electronic address: 348855048@qq.com.
Zitieren
APA
Huang, L., Liang, L., Ji, Z., Chen, S., Liu, M., Huang, Q., Huang, Z., Sun, S., Ding, J., Chen, J., Huang, X., Zheng, S., Deng, W., Huang, Y., & Li, T. (2023). Proteomics profiling of CD4 + T-cell-derived exosomes from patients with rheumatoid arthritis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110560
Vancouver
Huang L, Liang L, Ji Z, Chen S, Liu M, Huang Q, et al. Proteomics profiling of CD4 + T-cell-derived exosomes from patients with rheumatoid arthritis. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110560
BibTeX
@article{Huang2023,
author = {Huang, Lixin and Liang, Ling and Ji, Zhuyi and Chen, Shuyang and Liu, Meng and Huang, Qidang and Huang, Zhixiang and Sun, Shanmiao and Ding, Jiali and Chen, Jiajun and Huang, Xuechan and Zheng, Shaoling and Deng, Weiming and Huang, Yukai and Li, Tianwang},
title = {Proteomics profiling of CD4 + T-cell-derived exosomes from patients with rheumatoid arthritis},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110560}
}
EUVIMED